DirectSync Surgical

DirectSync Surgical is a private U.S. medical device company developing human-powered smart implants for spine and orthopedic applications. Its core technology is designed to use the patient’s own mechanical motion to generate localized electrical stimulation that promotes bone healing while also collecting post-operative implant data. The company’s lead product is a smart spinal fusion interbody device intended to improve fusion outcomes without batteries or external stimulators. DirectSync Surgical has highlighted FDA Breakthrough Device Designation for its spinal fusion device, NIH SBIR support, foundational intellectual property, and preclinical animal work. The company appears to be focused on translating its platform into first-in-human studies and broader load-bearing orthopedic implant applications.